BioCryst Reports Q3 Net Income of $0.14 Per Share
BioCryst reported Q3 net income of $0.14 per share, versus the FactSet estimate of $0.09.
Related stories
Grainger Q3 2026 EPS More Than Doubles
Grainger reported Q3 2026 revenue growth.
M impact | EARNINGS | Nov 04, 2026, 01:15 PM UTC
Sampo Raises 2026 Insurance Results Outlook
M impact | EARNINGS | Nov 04, 2026, 01:13 PM UTC
Sampo Raises 2026 Technical Result Forecast
Sampo raised its forecast for its 2026 technical result.
M impact | EARNINGS | Nov 04, 2026, 01:12 PM UTC
McDonald's Lowers Restaurant Construction Forecast to 2,500
McDonald's expects to build around 2,500 restaurants this year, down from earlier expectations of roughly 2,600, according to a Wednesday filing.
M impact | EARNINGS | Nov 04, 2026, 01:11 PM UTC
Charles River Laboratories Raises 2026 Outlook for Revenue Growth and EPS
The company raised its 2026 outlook for organic revenue growth and earnings per share. It now expects revenue to decline 1.5% to 2.0%.
M impact | EARNINGS | Nov 04, 2026, 01:11 PM UTC
Datadog Shares Plunge After Results; Q4 Forecast Below Expectations
Datadog shares fell sharply after the company reported results and issued a fourth-quarter forecast below expectations.
M impact | EARNINGS | Nov 04, 2026, 01:10 PM UTC